A new study published in the Journal of Internal Medicine showed that it may be possible to prevent the formation of ...

The current tuberculosis (TB) vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide, but it does not prevent the establishment of latent TB or ...

The country is bracing for great adversity in the health sector with hospitals calling for urgent measures to curb the ...

Today, bacillus Calmette–Guerin (BCG) vaccine is a well-established treatment for human bladder cancer that is arguably superior to intravesical chemotherapy for superficial disease and is ...

BCG (Bacillus Calmette-Guerin) vaccine for tuberculosis, pictured at the Pasteur Institute in Paris in 1931. Scientists in the UK have begun testing the BCG vaccine, developed in 1921, to see if ...

The BCG (Bacillus Calmette-Guerin) vaccine is made from a treated (attenuated) live strain of bacterium derived from Mycobacterium bovis, a bacterium which typically causes tuberculosis (TB ...

BCG (Bacillus Calmette - Guerin) vaccine is made from a treated (attenuated) live strain of bacterium derived from Mycobacterium bovis, a bacterium which typically causes tuberculosis (TB ...

Morales’s protocol of 6-weekly intravesical instillations of bacillus Calmette–Guerin (BCG), introduced in 1976, has survived to this date. BCG is superior to chemotherapy as an adjuvant agent ...

BCG or Bacillus Calmette-Guerin is a vaccine for tuberculosis (TB), a disease caused by an infection from Mycobacterium ...

Talk with your doctor to find out if you’re eligible. Bacillus Calmette-Guerin, originally a vaccine for tuberculosis, can ...

Accredited Social Health Activists (ASHAs) have surveyed communities to identify eligible individuals, finalising the list ...

Adjuvant, intravesical bacillus Calmette–Guérin (BCG) therapy reduces the risk of recurrence and progression of superficial bladder cancer, but confers a considerable risk of local and systemic ...